Technology Regulatory dogfight: Who should regulate genetically altered animals? Technology / 1 year ago by Dr. Peter G. Lurie, opinion contributor 07/01/23 2:00 PM ET
Healthcare FDA’s compounded drug list balances patient access and patient safety Healthcare / 3 years ago by Donald D. Ashley, opinion contributor 02/04/22 3:00 PM ET
Senate Biogen opens door to adjusting price of Alzheimer’s drug amid outcry Senate / 4 years ago by Peter Sullivan 06/23/21 1:58 PM ET
Health Care Infectious Disease Society says hydroxychloroquine should not be used to treat coronavirus patients Health Care / 4 years ago by Brooke Seipel 08/21/20 9:05 PM ET
Health Care FDA approves first-ever peanut allergy treatment Health Care / 5 years ago by Brooke Seipel 01/31/20 6:34 PM ET
Healthcare EpiPen price gouge proves pharma needs stringent controls Healthcare / 8 years ago by David S. Seres 09/13/16 10:41 AM ET
Healthcare FDA must focus on drug safety and effectiveness, not patients’ life outcomes Healthcare / 9 years ago by Joseph Gulfo 02/19/16 7:00 AM ET
Healthcare Appropriate oversight is needed to change FDA behaviors, not more laws Healthcare / 9 years ago by Joseph Gulfo 12/22/15 7:00 AM ET
Blog Briefing Room Pope: Legalizing drugs won’t help addiction Blog Briefing Room / 11 years ago by Mario Trujillo 06/20/14 8:29 AM ET
Politics Correcting a Morally Troublesome Matter Politics / 19 years ago by Mo. Dem. Rep. Ike Skelton 05/08/06 1:23 PM ET
